Gainers
- Prime Medicine (NASDAQ:PRME) stock moved upwards by 24.3% to $4.3 during Monday's pre-market session. The market value of their outstanding shares is at $516.1 million.
- Traws Pharma (NASDAQ:TRAW) stock increased by 16.2% to $6.67. The company's market cap stands at $20.1 million.
- Tharimmune (NASDAQ:THAR) shares increased by 14.28% to $2.8. The market value of their outstanding shares is at $3.2 million.
- Addex Therapeutics (NASDAQ:ADXN) shares increased by 13.81% to $10.3. The market value of their outstanding shares is at $11.0 million. As per the news, the Q2 earnings report came out today.
- BrainsWay (NASDAQ:BWAY) stock increased by 13.01% to $9.12. The company's market cap stands at $152.1 million.
- AnaptysBio (NASDAQ:ANAB) shares rose 9.82% to $35.0. The market value of their outstanding shares is at $1.0 billion.
Losers
- Ensysce Biosciences (NASDAQ:ENSC) shares fell 20.8% to $0.23 during Monday's pre-market session. The company's market cap stands at $1.9 million.
- Corvus Pharma (NASDAQ:CRVS) shares declined by 11.66% to $4.55. The company's market cap stands at $284.6 million.
- Protagenic Therapeutics (NASDAQ:PTIX) shares decreased by 11.28% to $0.55. The company's market cap stands at $2.4 million.
- Estrella Immunopharma (NASDAQ:ESLA) shares decreased by 10.93% to $1.06. The market value of their outstanding shares is at $38.5 million. As per the press release, Q4 earnings came out yesterday.
- Bionomics (NASDAQ:BNOX) stock declined by 10.13% to $0.57. The company's market cap stands at $7.6 million.
- Venus Concept (NASDAQ:VERO) shares decreased by 7.5% to $0.66. The market value of their outstanding shares is at $4.7 million.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
